Mini Review
Published on 11 Jan 2024
Role of sodium leak channel (NALCN) in sensation and pain: an overview
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1349438
- 2,729 views
- 2 citations
Type at least 3 characters
519 articles
Articles
Brief Research Report
Published on 15 Dec 2023
Inhibition of nicotinic acetylcholine receptors by oligoarginine peptides and polyamine-related compounds
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1327603
- 1,718 views
- 1 citation
Original Research
Published on 11 Dec 2023
Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1293578
- 2,279 views
Original Research
Published on 22 Nov 2023
Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1264216
- 2,254 views
Review
Published on 14 Nov 2023
News and views on ion channels in cancer: is cancer a channelopathy?
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1258933
- 3,546 views
- 4 citations
Original Research
Published on 14 Nov 2023
Structural modeling of hERG channel–drug interactions using Rosetta
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1244166
- 2,447 views
- 2 citations
Editorial
Published on 14 Nov 2023
Editorial: Real-world experience with CFTR modulator therapy
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1331829
- 1,116 views
Mini Review
Published on 07 Nov 2023
Vesicular CLC chloride/proton exchangers in health and diseases
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1295068
- 1,226 views
- 1 citation
Original Research
Published on 25 Oct 2023
Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1167407
- 1,654 views
- 1 citation
Review
Published on 24 Oct 2023
Ion channels in lung cancer: biological and clinical relevance
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1283623
- 2,493 views
- 1 citation
Original Research
Published on 17 Oct 2023
N-terminal region is responsible for mHv1 channel activity in MDSCs
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1265130
- 1,850 views
Review
Published on 28 Sep 2023
A review of the pathophysiology and the role of ion channels on bronchial asthma
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1236550
- 7,277 views
- 7 citations
Original Research
Published on 12 Sep 2023
Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1237431
- 1,697 views
- 5 citations
Review
Published on 24 Aug 2023
From squid giant axon to automated patch-clamp: electrophysiology in venom and antivenom research
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1249336
- 3,591 views
- 2 citations
Brief Research Report
Published on 16 Aug 2023
Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1210140
- 2,144 views
- 5 citations
Original Research
Published on 24 Jul 2023
Fluorescent membrane potential assay for drug screening on Kv10.1 channel: identification of BL-1249 as a channel activator
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1238503
- 3,238 views
- 1 citation